Yvan Butera
Dados Biográficos
| ID | 9799093 |
|---|---|
| NOME | Yvan Butera |
| PRENOMES | Yvan |
| SOBRENOME | Butera |
| ASSINATURA | BUTERA Y |
| AFILIAÇÕES | Rwanda Biomedical Center |
| ORCID | 0000-0002-0648-2384 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2024 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda
Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs emerged in Rwanda during the 1980s, prompting the policy shift towards adopting artemisinin-based combination therapies in 2006 as an alternative. However, recent findings from malaria surveillance and therapeutic efficacy studies have revealed a countrywide increase in antimalarial drug resistance. Particularly, artemether-lume…
South-to-south collaboration to strengthen the health workforce
Paediatric cardiovascular diseases have been referred to as diseases of injustice as access to care is inequitable globally. For example, Africa only has 78 cardiac centres, with 22 located in Sub-Saharan Africa. Most of these centres rely on visiting surgical teams to provide clinical care. While visiting surgical teams provide essential care, building a sustainable and locally run cardiac workforce in Africa is critical to addressing these ineq…
Sem obras proeminentes nesta página.
South-to-south collaboration to strengthen the health workforce
Paediatric cardiovascular diseases have been referred to as diseases of injustice as access to care is inequitable globally. For example, Africa only has 78 cardiac centres, with 22 located in Sub-Saharan Africa. Most of these centres rely on visiting surgical teams to provide clinical care. While visiting surgical teams provide essential care, building a sustainable and locally run cardiac workforce in Africa is critical to addressing these ineq…
Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda
Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs emerged in Rwanda during the 1980s, prompting the policy shift towards adopting artemisinin-based combination therapies in 2006 as an alternative. However, recent findings from malaria surveillance and therapeutic efficacy studies have revealed a countrywide increase in antimalarial drug resistance. Particularly, artemether-lume…
Amodiaquine (1 obras) · Cardiac surgery (1 obras) · Chloroquine (1 obras) · Combination therapy (1 obras) · Computational Drug Discovery Methods (1 obras) · Drug (1 obras) · Drug resistance (1 obras) · Drug-Induced Hepatotoxicity and Protection (1 obras) · Economic growth (1 obras) · Global Health and Surgery (1 obras)